AUM, Newsoara Biopharma to co-develop next-gen cancer therapeutics
Therapeutics | News | 0 Comment | 20 Nov, 2020
AUM Biosciences (AUM), a global, clinical-stage healthcare company based in Singapore, focused on discovering, acquiring...Read more
Taiwan discovers new gastric cancer biomarkers for tailored therapy
Therapeutics | News | 0 Comment | 17 Nov, 2020
A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua U...Read more
Singapore reveals novel method for cancer treatment
Therapeutics | News | 0 Comment | 16 Nov, 2020
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singa...Read more
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19
Therapeutics | News | 0 Comment | 09 Nov, 2020
Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...Read more
Celltrion's anti-COVID-19 monoclonal antibody treatment candidate looks promising
Therapeutics | News | 0 Comment | 09 Nov, 2020
Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...Read more
Singapore's single-cell precision medicine company 'Proteona' wins Start-up award
Therapeutics | News | 0 Comment | 09 Nov, 2020
Singapore single cell precision medicine company Proteona has been selected as one of the ten winners of Falling Walls B...Read more
Taiwan accelerates pace of gene-editing technologies into clinical settings
Therapeutics | News | 0 Comment | 06 Nov, 2020
In research endeavors to find a cure for many diseases, CRISPR/Cas9 has becoming a precise tool to modify the DNA in mic...Read more
Australia designs model to link heart disease with T2D
Therapeutics | News | 1 Comment | 04 Nov, 2020
Researchers from Australia's University of Sydney’s School of Project Management within the Faculty...Read more
Avatamed, Macrogen focus on personalized precision medicine services in cancer treatment
Therapeutics | News | 0 Comment | 04 Nov, 2020
AVATAMED, a precision medicine service company based in Singapore, represented by CEO Hong Boon Toh, has enter...Read more
SK Biopharma and LifeSci Venture Partners to push open innovation
Therapeutics | News | 0 Comment | 04 Nov, 2020
SK Biopharmaceuticals, a global innovative pharmaceutical company based in South Korea, has announced that the company h...Read more
PerkinElmer to acquire Horizon Discovery for $383M
Therapeutics | News | 0 Comment | 02 Nov, 2020
PerkinElmer, Inc. and Horizon Discovery Group plc have announced that they have reached an agreement on t...Read more
Ocumension strengthens pipeline for posterior segment eye diseases in China
Therapeutics | News | 0 Comment | 30 Oct, 2020
Hong Kong's Ocumension Therapeutics announced that the Company has entered into a collaboration and exclusive ...Read more
Singapore develops new gelatin microcarrier for cell production
Therapeutics | News | 0 Comment | 29 Oct, 2020
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise i...Read more
Samsung Biologics partners with Dinona for potential COVID-19 treatment
Therapeutics | News | 0 Comment | 21 Oct, 2020
Samsung Biologics has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities t...Read more
Axis Therapeutics, PharmaEssentia focus on providing TCR-T cell therapy in Taiwan
Therapeutics | News | 0 Comment | 15 Oct, 2020
Axis Therapeutics Limited based in the US and Hong Kong, a joint venture between Athenex, Inc. and Xiangxue Life Science...Read more
Merck launches VirusExpress platform to push cell and gene therapies
Therapeutics | News | 0 Comment | 14 Oct, 2020
Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentivir...Read more
Antengene partners with WuXi Biologics for innovative oncology medicines
Therapeutics | News | 0 Comment | 14 Oct, 2020
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...Read more
Korean startup Kanaph Therapeutics closes $21M Series B funding
Therapeutics | News | 0 Comment | 14 Oct, 2020
Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecul...Read more